Frontlight ResearchEarly access
Head and neck cancer trials in United States
391 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Active, not recruitingStudy of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors
- Where
- San Antonio, Spokane, Tyler
- Age
- 18 years and over
- People
- 140 worldwide
- Run by
- TiumBio Co., Ltd.
See details and how to joinNCT05784688 - Phase 2Taking peopleSingle-Center Eval of Clinical & Radiological Benefit AHCC in Combo W/ SOC Tx for HPV+ Pts W/ HNSCC
- Where
- Orange
- Age
- 18 years to 79 years
- People
- 34
- Run by
- University of California, Irvine
See details and how to joinNCT06693323 - No phaseCompletedSpecial Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy
- Where
- Baltimore, Cleveland, Columbus, New York
- Age
- 65 years and over
- People
- 1,500 worldwide
- Run by
- University Hospital Freiburg
See details and how to joinNCT05337631 - No phaseTaking peopleA Multicenter Cancer Biospecimen Collection Study
- Where
- San Francisco
- Age
- 18 years and over
- People
- 1,650
- Run by
- Cofactor Genomics, Inc.
See details and how to joinNCT04510129 - No phaseTaking peopleDetection of Oral and Throat Cancers Using OralViome Cancer Testing System
- Where
- New York
- Age
- 18 years and over
- People
- 475
- Run by
- Viome
See details and how to joinNCT05451303 - No phaseTaking peopleValidity of Viome's Oral/throat Cancer Test
- Where
- Memphis, St Louis
- Age
- 18 years and over
- People
- 1,000
- Run by
- Viome
See details and how to joinNCT06174428 - Phase 1/2Taking peopleSafety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer
- Where
- Irvine, Pittsburgh
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- CJ Bioscience, Inc.
See details and how to joinNCT05877430 - No phaseTaking peopleEMST in Patients Undergoing CRT for HNCA
- Where
- Milwaukee
- Age
- 18 years and over
- People
- 30
- Run by
- University of Wisconsin, Milwaukee
See details and how to joinNCT03916809 - Phase 2Taking peopleTreatment of Radiation and Cisplatin Induced Toxicities with Tempol
- Where
- La Jolla, Merced, San Francisco, Santa Maria, Seattle, The Bronx, Winston-Salem
- Age
- 18 years and over
- People
- 120
- Run by
- Matrix Biomed, Inc.
See details and how to joinNCT03480971 - Phase 1Enrolling by invitationStudy of Cemiplimab - TP Induction Chemotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck
- Where
- New York
- Age
- 18 years and over
- People
- 24
- Run by
- Krzysztof Misiukiewicz
See details and how to joinNCT05376553 - Phase 1/2Taking peoplePhase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
- Where
- Boston, Buffalo, Denver, New Haven, Scottsdale, Tampa
- Age
- 18 years and over
- People
- 316
- Run by
- Simcha IL-18, Inc.
See details and how to joinNCT04787042 - Phase 1/2Taking peopleGabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck Cancer
- Where
- Nashville
- Age
- 21 years and over
- People
- 64
- Run by
- Natalie Lockney
See details and how to joinNCT05156060 - Phase 1Taking peopleA Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors
- Where
- Jacksonville, Phoenix, Rochester, Scottsdale
- Age
- 18 years and over
- People
- 232
- Run by
- SparX Biotech(Jiangsu) Co., Ltd.
See details and how to joinNCT06259552 - Early phase 1Taking peopleImage-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation Therapy
- Where
- Nashville
- Age
- 18 years and over
- People
- 48
- Run by
- Vanderbilt-Ingram Cancer Center
See details and how to joinNCT05996432 - Phase 2Taking peopleTesting Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal Cancer
- Where
- Columbia
- Age
- 18 years and over
- People
- 28
- Run by
- University of Missouri-Columbia
See details and how to joinNCT04444869 - Phase 2Taking peoplePhase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
- Where
- Boston, New Haven, Richmond
- Age
- 18 years and over
- People
- 60 worldwide
- Run by
- IO Biotech
See details and how to joinNCT05280314